Arjunolic acid ameliorates reactive oxygen species via inhibition of p47(phox)-serine phosphorylation and mitochondrial dysfunction

The International Journal of Biochemistry & Cell Biology
Sumitra MiriyalaManikandan Panchatcharam

Abstract

Impaired cardiovascular function during acute myocardial infarction (MI) is partly associated with recruitment of activated polymorphonuclear neutrophils. The protective role of arjunolic acid (AA; 2,3,23-trihydroxy olean-12-en-28-oic acid) is studied in the modulation of neutrophil functions in vitro by measuring the reactive oxygen species (ROS) generation. Neutrophils were isolated from normal and acute MI mice to find out the efficacy of AA in reducing oxidative stress. Stimulation of neutrophils with phorbol-12-myristate-13-acetate (PMA) resulted in an oxidative burst of superoxide anion (O2(-)) and enhanced release of lysosomal enzymes. The treatment of neutrophils with PMA induced phosphorylation of Ser345 on p47(phox), a cytosolic component of NADPH oxidase. Furthermore, we observed activated ERK induced phosphorylation of Ser345 in MI neutrophils. Treatment with AA significantly inhibited the phosphorylation of P47(phox) and ERK in the stimulated controls and MI neutrophils. Oxidative phosphorylation activities in MI cells were lower than in control, while the glycolysis rates were elevated in MI cells compared to the control. In addition, we observed AA decreased intracellular oxidative stress and reduced the levels o...Continue Reading

References

Apr 4, 2003·Proceedings of the National Academy of Sciences of the United States of America·Tetsuro AgoHideki Sumimoto
Jun 25, 2003·Journal of the American College of Cardiology·Christophe HeymesAjay M Shah
Aug 12, 2004·Free Radical Biology & Medicine·Stephan BaldusThomas Münzel
Jun 17, 2006·The Journal of Clinical Investigation·Pham My-Chan DangJamel El-Benna
Feb 10, 2007·Cell·Denise Hilfiker-KleinerHelmut Drexler
Sep 15, 2007·Chemico-biological Interactions·Prasenjit MannaParames C Sil
Sep 19, 2007·Circulation·Renate Schnabel, Stefan Blankenberg
Apr 18, 2009·Experimental & Molecular Medicine·Jame El-BennaFrancoise Braut-Boucher
Sep 29, 2011·Journal of Molecular and Cellular Cardiology·Dan ShaoJunichi Sadoshima
Apr 11, 2012·Free Radical Research·Prasenjit Manna, Parames C Sil
Jul 3, 2013·Interactive Cardiovascular and Thoracic Surgery·Pankaj SaxenaIgor E Konstantinov
Jul 3, 2013·Oxidative Medicine and Cellular Longevity·Sumitra MiriyalaRengarajulu Puvanakrishnan
Jul 19, 2013·Oxidative Medicine and Cellular Longevity·Sumitra MiriyalaAnantharaman Muthuswamy
Aug 29, 2013·Clinical and Experimental Nephrology·Jan Willem Cohen Tervaert
Sep 21, 2013·Annual Review of Pathology·Tanya N MayadasClifford A Lowell

❮ Previous
Next ❯

Citations

Jun 8, 2021·Acta Pharmaceutica Sinica. B·Yanan HeDingkun Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.